Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

DCVAC add on to SOC (Carboplatin, Paclitaxel): until progression or intolerance or death

DCVAC +/- immune enhancers (Interferon-α and Hydroxychloroquine) add on to SOC (Carboplatin, Paclitaxel): until progression or intolerance or death

SOC (Carboplatin, Paclitaxel): until progression or intolerance or death